Matt Latham's practice focuses on mergers and acquisitions and private equity transactions. He has represented Australian and offshore acquirers and targets in a number of acquisitions, divestitures, take-private transactions, buyouts, and joint ventures. He also advises clients on various corporate-related matters, including directors' duties, corporate governance, and disclosure.
Matt has recently advised Australian Health Management in its A$367 million demutualisation and sale to Medibank Private; a consortium consisting of HarbourVest Partners, Paul Capital Partners, Pantheon Ventures, and Partners Group in its A$837 million take private of Macquarie Capital Group Alliance; and Bear Stearns Private Equity in its A$115 take private of Macquarie Private Capital Group.
Matt has published a number of articles and is a frequent speaker on mergers and acquisitions, private equity, and directors' duties.
经验
- February 23, 2010
2010 Speaker Series: Asia-Pacific, the Middle East, and Europe
- University of New South Wales (LL.B. 1992; B.A. 1992)
- New South Wales and Western Australia
- Spanish
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice